pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jun 2·1 min read
save

Eli Lilly gives hospitals five days to meet new 340B claims data policy or lose discounts

Jun 2, 2026·read at Endpoints ↗RegulatoryNegative

Eli Lilly has told a group of hospitals they must adhere to a new claims data policy within five days or their participation in the 340B drug discount program will be terminated.

The policy requires hospitals to submit detailed information on 340B prescription claims, which Lilly says is needed to verify that discounts are being applied correctly and to prevent misuse of the program.

Some health centers have pushed back, saying the request adds administrative burden and they have not been given sufficient time to adjust. If they do not comply, they risk losing the significant price reductions that 340B provides for eligible patients.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Lilly gives hospitals deadline to comply with 340B claims data policy”

read at Endpoints ↗
82 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLY5ELI LILLY CO2

related stories

  • Apr 30STAT+: FDA wants to exclude weight loss drugs from a compounding listSTAT
  • Apr 30STAT+: Five-way obesity drug is super effective — in miceSTAT
  • Apr 30Updated: Early sales of Lilly’s obesity pill appear to trail Novo’sEndpoints
  • Apr 29FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotechBioPharma Dive
  • Apr 29STAT+: A patent win for Pfizer and BridgeBioSTAT